These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21358539)

  • 1. A clinical report and further delineation of the 14q32 deletion syndrome.
    Youngs EL; Hellings JA; Butler MG
    Clin Dysmorphol; 2011 Jul; 20(3):143-147. PubMed ID: 21358539
    [No Abstract]   [Full Text] [Related]  

  • 2. Delineation of 14q32.3 deletion syndrome.
    Ortigas AP; Stein CK; Thomson LL; Hoo JJ
    J Med Genet; 1997 Jun; 34(6):515-7. PubMed ID: 9192277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal 14q32.33 deletion: genotype-phenotype correlation.
    Maurin ML; Brisset S; Le Lorc'h M; Poncet V; Trioche P; Aboura A; Labrune P; Tachdjian G
    Am J Med Genet A; 2006 Nov; 140(21):2324-9. PubMed ID: 17022077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14q32 deletion syndrome: a clinical report.
    Youngs EL; Dasouki M; Butler MG
    Clin Dysmorphol; 2012 Jan; 21(1):42-44. PubMed ID: 22143351
    [No Abstract]   [Full Text] [Related]  

  • 5. 14q32.3 deletion syndrome with autism.
    Merritt JL; Jalal SM; Barbaresi WJ; Babovic-Vuksanovic D
    Am J Med Genet A; 2005 Feb; 133A(1):99-100. PubMed ID: 15657934
    [No Abstract]   [Full Text] [Related]  

  • 6. A child with an inherited 0.31 Mb microdeletion of chromosome 14q32.33: further delineation of a critical region for the 14q32 deletion syndrome.
    Holder JL; Lotze TE; Bacino C; Cheung SW
    Am J Med Genet A; 2012 Aug; 158A(8):1962-6. PubMed ID: 22488736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic deletion in 14q32.3 through a de novo tandem translocation between 14q and 21p.
    Meschede D; Exeler R; Wittwer B; Horst J
    Am J Med Genet; 1998 Dec; 80(5):443-7. PubMed ID: 9880206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia.
    Geier CB; Piller A; Eibl MM; Ciznar P; Ilencikova D; Wolf HM
    Clin Immunol; 2017 Oct; 183():41-45. PubMed ID: 28705765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation.
    Corsello G; Salzano E; Vecchio D; Antona V; Grasso M; Malacarne M; Carella M; Palumbo P; Piro E; Giuffrè M
    Am J Med Genet A; 2015 Dec; 167A(12):3130-8. PubMed ID: 26333487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deletion 13q34/duplication 14q32.2-14q32.33 syndrome diagnosed 50 years after neonatal presentation as infantile hypercalcemia.
    Pallister PD; Pallister AB; South S; Toydemir R; Johnson JP; Beischel L; Opitz JM
    Am J Med Genet A; 2011 Apr; 155A(4):833-9. PubMed ID: 21595000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A child with terminal 14q deletion syndrome: consideration of genotype-phenotype correlations.
    Schlade-Bartusiak K; Ardinger H; Cox DW
    Am J Med Genet A; 2009 May; 149A(5):1012-8. PubMed ID: 19365838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DICER1 deletion and 14q32 microdeletion syndrome: an additional case and a review of the literature.
    Ting TW; Brett MS; Cham BW; Lim JY; Law HY; Tan EC; Lai AH; Jamuar SS
    Clin Dysmorphol; 2016 Jan; 25(1):37-40. PubMed ID: 26513514
    [No Abstract]   [Full Text] [Related]  

  • 13. New patients with Temple syndrome caused by 14q32 deletion: Genotype-phenotype correlations and risk of thyroid cancer.
    Severi G; Bernardini L; Briuglia S; Bigoni S; Buldrini B; Magini P; Dentici ML; Cordelli DM; Arrigo T; Franzoni E; Fini S; Italyankina E; Loddo I; Novelli A; Graziano C
    Am J Med Genet A; 2016 Jan; 170A(1):162-9. PubMed ID: 26333654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 14q32.2 Imprinted Region Disruption as an Alternative Molecular Diagnosis of Silver-Russell Syndrome.
    Geoffron S; Abi Habib W; Chantot-Bastaraud S; Dubern B; Steunou V; Azzi S; Afenjar A; Busa T; Pinheiro Canton A; Chalouhi C; Dufourg MN; Esteva B; Fradin M; Geneviève D; Heide S; Isidor B; Linglart A; Morice Picard F; Naud-Saudreau C; Oliver Petit I; Philip N; Pienkowski C; Rio M; Rossignol S; Tauber M; Thevenon J; Vu-Hong TA; Harbison MD; Salem J; Brioude F; Netchine I; Giabicani E
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2436-2446. PubMed ID: 29659920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of 14q32 in human neuroblastoma defines an 1,100-kb region of common allelic loss.
    Hoshi M; Shiwaku HO; Hayashi Y; Kaneko Y; Horii A
    Med Pediatr Oncol; 2000 Dec; 35(6):522-5. PubMed ID: 11107107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further delineation of the chromosome 14q terminal deletion syndrome.
    van Karnebeek CD; Quik S; Sluijter S; Hulsbeek MM; Hoovers JM; Hennekam RC
    Am J Med Genet; 2002 Jun; 110(1):65-72. PubMed ID: 12116274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the ocular phenotype of 14q terminal deletions: A novel presentation of microphthalmia and coloboma in ring 14 syndrome with associated 14q32.31 deletion and review of the literature.
    Salter CG; Baralle D; Collinson MN; Self JE
    Am J Med Genet A; 2016 Apr; 170A(4):1017-22. PubMed ID: 26773965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proximal chromosome 14q microdeletion syndrome: delineation of the phenotype using high resolution SNP oligonucleotide microarray analysis (SOMA) and review of the literature.
    Torgyekes E; Shanske AL; Anyane-Yeboa K; Nahum O; Pirzadeh S; Blumfield E; Jobanputra V; Warburton D; Levy B
    Am J Med Genet A; 2011 Aug; 155A(8):1884-96. PubMed ID: 21744488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors.
    Herriges JC; Brown S; Longhurst M; Ozmore J; Moeschler JB; Janze A; Meck J; South ST; Andersen EF
    Eur J Med Genet; 2019 Jan; 62(1):9-14. PubMed ID: 29698806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phenotype map for 14q32.3 terminal deletions.
    Engels H; Schüler HM; Zink AM; Wohlleber E; Brockschmidt A; Hoischen A; Drechsler M; Lee JA; Ludwig KU; Kubisch C; Schwanitz G; Weber RG; Leube B; Hennekam RC; Rudnik-Schöneborn S; Kreiss-Nachtsheim M; Reutter H
    Am J Med Genet A; 2012 Apr; 158A(4):695-706. PubMed ID: 22367666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.